1. MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF
- Author
-
Ji-Fu E, Wei Zhang, Yong-Gang Hong, Cheng Xin, Pengpeng Li, Qizhi Liu, Liqiang Hao, Xianhua Gao, and Zhi-ping Huang
- Subjects
0301 basic medicine ,Adult ,Male ,Colorectal cancer ,Mice, Nude ,medicine.disease_cause ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,Cell Line, Tumor ,microRNA ,medicine ,HDGF ,Animals ,Humans ,lcsh:QH301-705.5 ,Aged ,Cell Proliferation ,lcsh:R5-920 ,MicroRNA-95-3p ,Oncogene ,Cell growth ,business.industry ,Cancer ,General Medicine ,Biomarker ,Middle Aged ,medicine.disease ,Prognosis ,digestive system diseases ,Gene Expression Regulation, Neoplastic ,Colorectal carcinoma ,MicroRNAs ,030104 developmental biology ,lcsh:Biology (General) ,030220 oncology & carcinogenesis ,Cancer research ,Intercellular Signaling Peptides and Proteins ,Original Article ,Female ,Carcinogenesis ,business ,lcsh:Medicine (General) ,Colorectal Neoplasms - Abstract
Background MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. MiR-95-3p has been reported to be an oncogene in hepatocellular carcinoma. However, the role of miR-95-3p in colorectal carcinoma (CRC) remains unclear. Methods miR-95-3p was validated in an independent validation sample cohort of 215 CRC tissues. Functional assays, Cell proliferation (MTT) assay colony formation, wound healing, transwell and animal xenograft assays were used to determine the oppressor role of miR-95-3p in human CRC progression. Furthermore, Bioinformatics analysis, western blotting and dual-luciferase reporter assay were used to determine the mechanism by which miR-95-3p suppresses progression of CRC cells. Results In this study, we found that miR-95-3p was downregulated in CRC tissues. The low level of miR-95-3p in CRC tumors was correlated with aggressive clinicopathological characteristics, and it predicted poor prognosis in CRC patients. The overexpression of miR-95-3p significantly inhibited CRC cell proliferation, colony formation and metastasis in vitro and in vivo. Bioinformatic analysis further identified hepatoma-derived growth factor (HDGF) as a novel target of miR-95-3p in CRC cells. These findings suggest that miR-95-3p regulates CRC cell survival, partially through the downregulation of HDGF. Conclusions Therefore, the miR-95-3p/HDGF axis might serve as a novel therapeutic target in patients with CRC.
- Published
- 2020